Your browser doesn't support javascript.
loading
Identification of novel genetic loci for risk of multiple myeloma by functional annotation.
Macauda, Angelica; Briem, Klara; Clay-Gilmour, Alyssa; Cozen, Wendy; Försti, Asta; Giaccherini, Matteo; Corradi, Chiara; Sainz, Juan; Niazi, Yasmeen; Ter Horst, Rob; Li, Yang; Netea, Mihai G; Vogel, Ulla; Hemminki, Kari; Slager, Susan L; Varkonyi, Judit; Andersen, Vibeke; Iskierka-Jazdzewska, Elzbieta; Mártinez-Lopez, Joaquin; Zaucha, Jan; Camp, Nicola J; Rajkumar, S Vincent; Druzd-Sitek, Agnieszka; Bhatti, Parveen; Chanock, Stephen J; Kumar, Shaji K; Subocz, Edyta; Mazur, Grzegorz; Landi, Stefano; Machiela, Mitchell J; Jerez, Andrés; Norman, Aaron D; Hildebrandt, Michelle A T; Kadar, Katalin; Berndt, Sonja I; Ziv, Elad; Buda, Gabriele; Nagler, Arnon; Dumontet, Charles; Razny, Malgorzata; Watek, Marzena; Butrym, Aleksandra; Grzasko, Norbert; Dudzinski, Marek; Rybicka-Ramos, Malwina; Matera, Eva-Laure; García-Sanz, Ramón; Goldschmidt, Hartmut; Jamroziak, Krzysztof; Jurczyszyn, Artur.
Afiliação
  • Macauda A; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Briem K; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Clay-Gilmour A; Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
  • Cozen W; Division of Hematology/Oncology, Division of Hematology/Oncology, Department of Medicine, School of Medicine, Department of Pathology, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California at Irvine, Irvine, CA, USA.
  • Försti A; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Giaccherini M; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Corradi C; Department of Biology, University of Pisa, Pisa, Italy.
  • Sainz J; Department of Biology, University of Pisa, Pisa, Italy.
  • Niazi Y; Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS, Granada, Spain.
  • Ter Horst R; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain.
  • Li Y; Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.
  • Netea MG; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Vogel U; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Hemminki K; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Slager SL; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Varkonyi J; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Andersen V; Centre for Individualised Infection Medicine (CiiM) & TWINCORE, joint ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Iskierka-Jazdzewska E; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Mártinez-Lopez J; Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany.
  • Zaucha J; National Research Centre for the Working Environment, Copenhagen, Denmark.
  • Camp NJ; Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic.
  • Rajkumar SV; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Druzd-Sitek A; Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Bhatti P; Department of Hematology, Semmelweis University, Budapest, Hungary.
  • Chanock SJ; Molecular Diagnostics and Clinical Research Unit, Institute of Regional Health Research, University Hospital of Southern Denmark, Odense, Denmark.
  • Kumar SK; Institute of Regional Research, University of Southern Denmark, Odense, Denmark.
  • Subocz E; Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Mazur G; Department of Hematology, Transplantology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Landi S; Hospital Universitario 12 de Octubre, Instituto de Investigación del Hospital Universitario 12 de Octubre, 28041, Madrid, Spain.
  • Machiela MJ; Department of Haematology & Transplantology, Medical University of Gdansk, Gdansk, Poland.
  • Jerez A; Division of Hematology and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Norman AD; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Hildebrandt MAT; Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Kadar K; Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
  • Berndt SI; Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Ziv E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Buda G; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Nagler A; Department of Hematology, Warmian-Masurian Cancer Center of The Ministry Of The Interior And Administration's Hospital, Olsztyn, Poland.
  • Dumontet C; Wroclaw Medical University, Wroclaw, Poland.
  • Razny M; Department of Biology, University of Pisa, Pisa, Italy.
  • Watek M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Butrym A; Hematology and Medical Oncology Department, University Hospital Morales Meseguer, IMIB, Murcia, Spain.
  • Grzasko N; Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Dudzinski M; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Rybicka-Ramos M; Department of Lymphoma - Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Matera EL; St. John's Hospital, Budapest, Hungary.
  • García-Sanz R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Goldschmidt H; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
  • Jamroziak K; Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Jurczyszyn A; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel.
Leukemia ; 37(11): 2326-2329, 2023 11.
Article em En | MEDLINE | ID: mdl-37723249
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article